Comparison of the in vivo coronary action of endothelin-1 and vasopressin: Role of nitric oxide and prostanoids

Vascular Pharmacology

Volumn 40, Issue 5, 2003, Pages 247-252

  Martínez, María Angeles ^a   Fernández, Nuria ^a   García Villalón, Angel Luis ^a   Monge, Luis ^a   Diéguez, Godofredo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Coronary flow; Endothelin 1; Ischemia; Nitric oxide; Vasopressin

Indexed keywords

CYCLOOXYGENASE MECLOFENAMATE; ENDOTHELIN 1; MECLOFENAMIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PEPTIDE DERIVATIVE; PROSTANOID; UNCLASSIFIED DRUG; VASOPRESSIN;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; CARDIOVASCULAR EFFECT; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY CONSTRICTION; DRUG ACTIVITY; DRUG POTENCY; ELECTROMAGNETIC FIELD; FEMALE; GOAT; INJECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; REDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIN-1; ENZYME INHIBITORS; FEMALE; GOATS; MECLOFENAMIC ACID; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PROSTAGLANDINS; VASOPRESSINS;

EID: 18744422670     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2004.01.001     Document Type: Article

References (34)

1. Bassenge E. Control of coronary blood flow by autacoids. Basic Res. Cardiol. 90:1995;125-141.
2. Brown W.E. The coronary collateral circulation in normal goats. J. Surg. Res. 51:1991;54-59.
3. Chester A.H., Dashwood M.R., Clarke J.G., Larkin S.W., Davies G.J., Tadjkrimi S., Maseri A., Yacoub M.H. Influence of endothelin on human coronary arteries and localization of its binding sites. Am. J. Cardiol. 63:1989;1395-1398.
4. Cowley A.W. Jr. Vasopressin and blood pressure regulation. Clin. Physiol. Biochem. 6:1988;150-162.
5. Cowley A.W. Jr., Liard J.-F. Cardiovascular actions of vasopressin. Gash D.M., Plenum G.J. Vasopressin: Principles and Properties. 1987;389-433 Boer, New York.
6. Ezra D., Godstein R.E., Czaja J.F., Feuerstein G.Z. Lethal ischemia due to intracoronary endothelin in pigs. Am. J. Physiol. 257:1989;H339-H343.
7. 2 receptors and nitric oxide. Eur. J. Pharmacol. 342:1998;225-233.
8. Fernández N., Martínez M.A., Climent B., García-Villalón A.L., Monge L., Sanz E., Diéguez G. Coronary reactivity to endothelin-1 during partial ischemia and reperfusion in anesthetized goats. Role of nitric oxide and prostanoids. Eur. J. Pharmacol. 457:2002;161-168.
9. Franco-Cereceda A. Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro. Br. J. Pharmacol. 97:1989;968-972.
10. García J.L., Fernández N., García-Villalón A.L., Monge L., Gómez B., Diéguez G. Effects of nitric oxide synthesis inhibition on the goat coronary circulation under basal conditions and after vasodilator stimulation. Br. J. Pharmacol. 106:1992;563-567.
11. García J.L., Fernández N., García-Villalón A.L., Monge L., Gómez B., Diéguez G. Coronary vasoconstriction by endothelin-1 in anesthetized goats: role of endothelin receptors, nitric oxide and prostanoids. Eur. J. Pharmacol. 315:1996;179-186.
12. García-Villalón A.L., García J.L., Fernández N., Monge L., Gómez B., Diéguez G. Regional difference in the arterial response to vasopressin: role of endothelin nitric oxide. Br. J. Pharmacol. 118:1996;1848-1854.
13. Hart G., Gokal R. The syndrome of inappropriate antidiuretic hormone secretion associated with acute myocardial infarction. J. Postgrad. Med. 53:1977;761-763.
14. Heyndrickx G.R., Boettcher D.H., Vatner V. Effects of angiotensin, vasopressin and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am. J. Physiol. 231:1976;1579-1589.
15. Ihara M., Saeki K., Funabashi K., Nakamichi M., Yano M., Fukuroda T., Miyaji M., Nishikibe M., Ikemoto F. Two endothelin receptor subtypes in porcine arteries. J. Cardiovasc. Pharmacol. 17(Suppl. 7):1991;S119.
16. Karwatowska-Prokopczuk E., Wennmalm A. Effects of endothelin on coronary flow, mechanical performance, oxygen uptake, and formation of purines and on outflow of prostacyclin in the isolated rabbit heart. Circ. Res. 66:1990;46-54.
17. Khayyal M.A., Eng C., Franzen D., Breall J.A., Kirk E.S. Effects of vasopressin on the coronary circulation: reserve and regulation during ischemia. Am. J. Physiol. 248:1985;H516-H522.
18. Krajcar M., Heusch G. Local and neurohumoral control of coronary blood flow. Basic Res. Cardiol. 88(Suppl. 1):1993;25-42.
19. Lee S.L., Levitsky S., Feinberg H. Endogenous vasoconstrictor prostanoids: role in serotonin and vasopressin-induced coronary vasoconstriction. J. Pharmacol. Exp. Ther. 258:1991;292-298.
20. Lipovetsky G., Fenoglio J.J., Gieger M., Srinivasan M.R., Dobelle W.H. Coronary artery anatomy of the goat. Artif. Organs. 7:1993;238-245.
21. Martínez M.A., Fernández N., Climent B., García-Villalón A.L., Monge L., Sanz E., Diéguez G. Coronary effects of vasopressin during partial ischemia and reperfusion in anesthetized goats. Role of nitric oxide and prostanoids. Eur. J. Pharmacol. 473:2003;55-63.
22. Masaki T. Possible role of endothelin in endothelial regulation of vascular tone. Annu. Rev. Pharmacol. Toxicol. 35:1995;235-255.
23. Maturi M.F., Martín S.E., Markle D., Maxwell M., Burruss C.R., Speir E., Greene R., Ro Y.M., Vitale D., Green M.V., Goldstein S.R., Bacharach S.L., Patterson R.E. Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels. Circulation. 83:1991;2111-2121.
24. Miyauchi T., Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol. 61:1999;391-415.
25. Myers P.R., Banitt P.F., Guerra R. Jr., Harrison D.G. Characteristics of canine coronary resistance arteries: importance of endothelium. Am. J. Physiol. 257:1989;H603-H610.
26. Parent R., Lavalle M. Endothelin-dependent effects limit flow-induced dilation of conductance coronary vessels after blockade of nitric oxide formation in conscious dogs. Cardiovasc. Res. 45:2000;470-477.
27. Rapps J.A., Jones A.W., Sturek M., Magliola L., Parker J.L. Mechanisms of altered contractile responses to vasopressin and endothelin in canine coronary collateral arteries. Circulation. 95:1997;231-239.
28. Schafer U., Kurz T., Jain D., Hartmann F., Dendorfer A., Tolg R., Raasch W., Dominiak P., Katus H., Richardt G. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation? Basic Res. Cardiol. 97:2002;399-408.
29. Serradeil-Le-Gal C., Villanova G., Boutin M., Maffrand J.P., Le-Fur G. Effects of SR 49059, a non-peptide antagonist of vasopressin V1a receptors, on vasopressin-induced coronary vasoconstriction in conscious rabbits. Fundam. Clin. Pharmacol. 9:1995;17-24.
30. Tamirisa P., Frishman W.H., Kumar A. Endothelin and endothelin antagonism: roles in cardiovascular health and disease. Am. Heart J. 130:1995;601-610.
31. Walker B.R., Brizzee B.L., Harrison-Bernard L.M. Potentiated vasoconstrictor response to vasopressin following meclofenamate in conscious rats. Proc. Soc. Exp. Biol. Med. 187:1988;157-164.
32. Wang Q.-D., Li M.-S., Pernow J. Characterization of endothelin-1-induced vascular effects in the rat heart by using endothelin receptor antagonists. Eur. J. Pharmacol. 271:1994;25-30.
33. Wilson M.F., Brackett D.J., Archer L.T., Hinshaw L.B. Mechanism of impaired cardiac function by vasopressin. Ann. Surg. 191:1980;494-500.
34. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 33:1988;411-415.